For example, in ovarian cancer, psoriatic skin, cutaneous squamous cell cancers and cholangiocarcinoma patients ISG12 over-expression has been associated to epithelial proliferation, epithelial–mesenchymal transition, cell cycling and tumorigenicity (38, 54–56). This evidence concerns the gene IFI27 and cholangiocarcinoma.